← United States · Coverage record
US · SEC FORM 4
Oncology Institute, Inc.
TOI · Nasdaq; OTC · CIK 0001799191 · Healthcare
INSIDER SIGNAL
1 buyers · 7 purchase transaction lines · $609.3K gross purchase
WHY THIS SIGNAL?
Score anatomy
Each bar shows the contribution to the current score; the weights and formula stay unchanged.
What is holding the score back?
- ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
- ⚠ Role scores low · most senior buyer: TenPercentOwner (CEO, chair and 10% owners score lowest)
- ⚠ Purchase activity is becoming less recent
- ⚠ Buying conviction is reduced by concurrent selling
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 5 additional owner(s) remain in Form 4 evidence.
Purchase breadth & concentration
Roles in the peak window: TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.
SIGNAL HISTORY
Latest recorded score
- 36.9
- 41.8
- 41.8
- 41.7
- 41.6
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
The FINRA report lists no short interest for this ticker.
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-14 | Chernett Jorey | Purchase (P) | Common Stock | 12,000 | USD 6.54 | USD 78,480 | SEC filing ↗ |
| 2026-07-21 | Chernett Jorey | Purchase (P) | Common Stock | 18,000 | USD 5.27 | USD 94,860 | SEC filing ↗ |
| 2026-07-10 | Chernett Jorey | Purchase (P) | Common Stock | 15,000 | USD 5.85 | USD 87,750 | SEC filing ↗ |
| 2026-06-23 | Chernett Jorey | Purchase (P) | Common Stock | 18,000 | USD 5.02 | USD 90,360 | SEC filing ↗ |
| 2026-06-04 | Chernett Jorey | Purchase (P) | Common Stock | 12,000 | USD 4.75 | USD 57,000 | SEC filing ↗ |
| 2026-05-20 | Chernett Jorey | Purchase (P) | Common Stock | 33,500 | USD 4.07 | USD 136,345 | SEC filing ↗ |
| 2026-05-19 | Chernett Jorey | Purchase (P) | Common Stock | 5,000 | USD 4.05 | USD 20,250 | SEC filing ↗ |
| 2026-05-19 | Chernett Jorey | Purchase (P) | Common Stock | 30,000 | USD 4.09 | USD 122,700 | SEC filing ↗ |
| 2026-04-09 | Chernett Jorey | Purchase (P) | Common Stock | 20,000 | USD 3.10 | USD 62,000 | SEC filing ↗ |
| 2026-03-27 | Chernett Jorey | Purchase (P) | Common Stock | 27,429 | USD 2.96 | USD 81,190 | SEC filing ↗ |
| 2026-03-26 | Chernett Jorey | Purchase (P) | Common Stock | 50,000 | USD 3.15 | USD 157,500 | SEC filing ↗ |
| 2026-03-24 | Chernett Jorey | Purchase (P) | Common Stock | 125,000 | USD 3.11 | USD 388,750 | SEC filing ↗ |
| 2026-03-20 | Chernett Jorey | Purchase (P) | Common Stock | 25,000 | USD 3.35 | USD 83,750 | SEC filing ↗ |
| 2026-03-17 | Chernett Jorey | Purchase (P) | Common Stock | 75,000 | USD 3.42 | USD 256,500 | SEC filing ↗ |
| 2026-03-16 | Chernett Jorey | Purchase (P) | Common Stock | 60,985 | USD 3.29 | USD 200,641 | SEC filing ↗ |
Form 4 evidence
67 transaction lines in the latest 365-day window; 334 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-21 | Hively Brad | Sale (S) | Common Stock | 298,853 | USD 6.51 | USD 1,945,533 | SEC filing ↗ |
| 2026-08-14 | Chernett Jorey | Purchase (P) | Common Stock | 12,000 | USD 6.54 | USD 78,480 | SEC filing ↗ |
| 2026-07-27 | TZOUMAKAS KIMBERLY JO | Award / grant (A) | Common Stock | 29,116 | USD 0.00 | USD 0 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-21 | Hively Brad | Sale (S) | Common Stock | 298,853 | USD 6.51 | USD 1,945,533 | SEC filing ↗ |
| 2026-08-14 | Chernett Jorey | Purchase (P) | Common Stock | 12,000 | USD 6.54 | USD 78,480 | SEC filing ↗ |
| 2026-07-27 | TZOUMAKAS KIMBERLY JO | Award / grant (A) | Common Stock | 29,116 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-27 | STOLPER MARK | Award / grant (A) | Common Stock | 31,124 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-27 | Pacala Mark L | Award / grant (A) | Common Stock | 30,120 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-27 | McGeorge Anne | Award / grant (A) | Common Stock | 41,165 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-27 | Kaushal Mohit | Award / grant (A) | Common Stock | 33,133 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-27 | Johnson Karen Marie | Award / grant (A) | Common Stock | 31,124 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-27 | Hively Brad | Award / grant (A) | Common Stock | 27,108 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-21 | Chernett Jorey | Purchase (P) | Common Stock | 18,000 | USD 5.27 | USD 94,860 | SEC filing ↗ |
| 2026-07-14 | Podnos Yale | Sale (S) | Common Stock | 23,452 | USD 6.41 | USD 150,358 | SEC filing ↗ |
| 2026-07-14 | Podnos Yale | Option exercise / conversion (M) | Common Stock | 23,452 | USD 1.90 | USD 44,567 | SEC filing ↗ |
| 2026-07-10 | Chernett Jorey | Purchase (P) | Common Stock | 15,000 | USD 5.85 | USD 87,750 | SEC filing ↗ |
| 2026-07-07 | TZOUMAKAS KIMBERLY JO | Award / grant (A) | Common Stock | 17,185 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-07 | STOLPER MARK | Award / grant (A) | Common Stock | 25,833 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-23 | Chernett Jorey | Purchase (P) | Common Stock | 18,000 | USD 5.02 | USD 90,360 | SEC filing ↗ |
| 2026-06-08 | Podnos Yale | Sale (S) | Common Stock | 23,451 | USD 5.38 | USD 126,166 | SEC filing ↗ |
| 2026-06-04 | Chernett Jorey | Purchase (P) | Common Stock | 12,000 | USD 4.75 | USD 57,000 | SEC filing ↗ |
| 2026-05-21 | Virnich Daniel | J (J) | Common Stock | 23,058 | USD 4.47 | USD 103,069 | SEC filing ↗ |
| 2026-05-21 | Podnos Yale | J (J) | Common Stock | 1,805 | USD 4.47 | USD 8,068 | SEC filing ↗ |
| 2026-05-21 | Carter Robert Ross | J (J) | Common Stock | 1,604 | USD 4.47 | USD 7,170 | SEC filing ↗ |
| 2026-05-20 | Chernett Jorey | Purchase (P) | Common Stock | 33,500 | USD 4.07 | USD 136,345 | SEC filing ↗ |
| 2026-05-19 | Chernett Jorey | Purchase (P) | Common Stock | 5,000 | USD 4.05 | USD 20,250 | SEC filing ↗ |
| 2026-05-19 | Chernett Jorey | Purchase (P) | Common Stock | 30,000 | USD 4.09 | USD 122,700 | SEC filing ↗ |
| 2026-04-16 | Kaushal Mohit | Sale (S) | Common Stock | 38,433 | USD 3.50 | USD 134,516 | SEC filing ↗ |
| 2026-04-14 | Kaushal Mohit | Sale (S) | Common Stock | 57,286 | USD 3.50 | USD 200,501 | SEC filing ↗ |
| 2026-04-09 | Chernett Jorey | Purchase (P) | Common Stock | 20,000 | USD 3.10 | USD 62,000 | SEC filing ↗ |
| 2026-03-27 | Chernett Jorey | Purchase (P) | Common Stock | 27,429 | USD 2.96 | USD 81,190 | SEC filing ↗ |
| 2026-03-26 | Chernett Jorey | Purchase (P) | Common Stock | 50,000 | USD 3.15 | USD 157,500 | SEC filing ↗ |
| 2026-03-24 | Chernett Jorey | Purchase (P) | Common Stock | 125,000 | USD 3.11 | USD 388,750 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | TOI |
| CIK | 0001799191 |
| Sector | Healthcare |
| Industry | — Yahoo Finance |
| SEC SIC | 8011 Services-Offices & Clinics of Doctors of Medicine |
| Exchange | Nasdaq; OTC |
Data coverage
| Local Form 4 history | 334 transaction lines from 2020-03-13 to 2026-08-21 42 P purchase lines · 99 S sale lines · 193 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.